Treatment with non‐selective beta‐blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis

BACKGROUND & AIMS: The use of non‐selective beta‐blockers has been associated with lower rates of infection and reduced infection‐associated morbidity in patients with cirrhosis. However, it is unknown if these drugs modify the systemic inflammatory response to circulating bacterial DNA. METHODS...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Liver Int
Главные авторы: Gimenez, Paula, Garcia‐Martinez, Irma, Francés, Rubén, Gonzalez‐Navajas, Jose M., Mauri, Montserrat, Alfayate, Rocío, Almenara, Susana, Miralles, Cayetano, Palazon, Jose M., Carnicer, Fernando, Pascual, Sonia, Such, José, Horga, José F., Zapater, Pedro
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2018
Предметы:
Cirrhosis and Liver Failure
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6282820/
https://ncbi.nlm.nih.gov/pubmed/29802788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.13890
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы